Full Text View
Tabular View
No Study Results Posted
Related Studies
RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease
This study has been terminated.
Study NCT00060515   Information provided by Repligen Corporation
First Received: May 7, 2003   Last Updated: August 4, 2005   History of Changes

No Study Results Posted for this Study
About Study Results Reporting
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given